Earnings Call · Q2 FY2024·2024-08-12

Q2 24EPS -21.43%·Rev n/aQ1 24EPS -100.00%*·Rev n/aQ4 23EPS -50.00%·Rev n/aQ3 23EPS +100.00%*·Rev n/a⚠ consensus missing

Journey Medical Corp DERM

Jaclyn Jaffe — Senior Director of Corporate Operations

Claude Maraoui — Co-Founder, President and Chief Executive Officer

Joseph Benesch — Chief Financial Officer

+14.2%1d on move date+12.6% vs SPY3d+8.1%5d+8.3%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DERM calls or request research access.

More DERM calls Browse calls Request research access